Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 5
1958 5
1961 3
1962 2
1963 3
1964 2
1965 5
1966 6
1967 2
1968 4
1969 5
1970 4
1971 7
1972 9
1973 7
1974 4
1975 5
1976 5
1977 3
1978 3
1979 2
1980 1
1981 2
1982 2
1983 2
1984 3
1985 5
1986 3
1987 1
1988 4
1989 2
1990 2
1993 4
1994 3
1995 5
1996 3
1997 3
1998 3
2000 3
2001 6
2002 10
2003 7
2004 12
2005 4
2006 9
2007 12
2008 14
2009 15
2010 17
2011 17
2012 19
2013 24
2014 18
2015 17
2016 21
2017 23
2018 15
2019 22
2020 41
2021 43
2022 38
2023 29
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K; SURPASS-2 Investigators. Frías JP, et al. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. N Engl J Med. 2021. PMID: 34170647 Clinical Trial.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML; Retatrutide Phase 2 Obesity Trial Investigators. Jastreboff AM, et al. N Engl J Med. 2023 Aug 10;389(6):514-526. doi: 10.1056/NEJMoa2301972. Epub 2023 Jun 26. N Engl J Med. 2023. PMID: 37366315 Clinical Trial.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Nutritional Biochemistry.
Hsia SM. Hsia SM. Int J Mol Sci. 2023 Jun 2;24(11):9661. doi: 10.3390/ijms24119661. Int J Mol Sci. 2023. PMID: 37298610 Free PMC article.
The expanding functions of thyroid hormone.
Wong J, Hsia SV. Wong J, et al. Among authors: hsia sv. Cell Biosci. 2017 Oct 19;7:53. doi: 10.1186/s13578-017-0176-0. eCollection 2017. Cell Biosci. 2017. PMID: 29075436 Free PMC article. No abstract available.
In-hospital care of children with COVID-19.
Chan OW, Lee EP, Chou CC, Lai SH, Chung HT, Lee J, Lin JJ, Hsieh KS, Hsia SH. Chan OW, et al. Among authors: hsia sh. Pediatr Neonatol. 2024 Jan;65(1):2-10. doi: 10.1016/j.pedneo.2023.02.009. Epub 2023 Oct 21. Pediatr Neonatol. 2024. PMID: 37989708 Free article. Review.
534 results